Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Inspiremd Inc's Business Segments
Inspiremd Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
2
Largest Segment
Other Countries
Total Revenue
$ 2
Regions Reported
1
Revenue Share by Reportable Segment - FY
- Other Countries0%
- Customer B19.6%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Other Countries | $ 2 | - |
| Customer B | $ 0 | 19.6% |
Revenue Share by Region - FY
- Other Countries62.7%
Revenue by Geographic Region - FY
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Other Countries | $ 1 | 62.7% |
Annual Results
Revenue Share by Reportable Segment - FY
- Other Countries0%
- Customer B19.6%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Other Countries | $ 2 | - |
| Customer B | $ 0 | 19.6% |
Description of Inspiremd Inc
InspireMD Inc is a medical device company based in Tel Aviv, Israel. The company specializes in the development and commercialization of proprietary therapeutic vascular devices, primarily designed for the treatment of acute coronary syndromes (ACS), which is a condition caused by reduced blood flow to the heart.
One of InspireMD's main products is the CGuard Embolic Prevention System (EPS), which is a stent platform used to treat coronary artery disease. This innovative system is designed with a unique mesh shield that helps prevent the release of plaque and blood clots during and after stent placement, reducing the risk of complications such as strokes and heart attacks.
The CGuard EPS is built on the company's MicroNet technology, a specialized mesh material that offers superior embolic protection compared to traditional stenting procedures. The MicroNet technology acts as a barrier by capturing and containing debris that may break off during stent placement, preventing it from reaching vital organs such as the brain or heart.
The CGuard EPS has received regulatory approvals in various regions around the world, including the CE Mark in Europe and clearance from the US Food and Drug Administration (FDA). This regulatory success has allowed InspireMD to market and sell their product to healthcare professionals globally.
InspireMD is known for its dedication to research and development (R&D) and continually strives to improve and expand their product offerings. The company conducts numerous clinical trials and collaborations with leading medical institutions to gain valuable insights and validate the effectiveness of their technologies.
Furthermore, InspireMD has a strong focus on commercialization, forging strategic partnerships with distributors and healthcare companies to ensure widespread adoption of their products. They have established a global sales network to reach healthcare providers and patients in different countries.
Apart from the CGuard EPS, InspireMD also develops and markets other products for the treatment of various cardiovascular conditions. These include the MGuard Prime Embolic Protection System, which provides embolic protection during the treatment of heart attack patients.
Overall, InspireMD Inc is a leading medical device company that pioneers innovative solutions for the treatment of acute coronary syndromes. They are committed to improving patient outcomes by reducing the risk of complications associated with traditional stenting procedures. With their cutting-edge technology, extensive research, and strategic partnerships, InspireMD continues to make significant contributions to the field of interventional cardiology.
One of InspireMD's main products is the CGuard Embolic Prevention System (EPS), which is a stent platform used to treat coronary artery disease. This innovative system is designed with a unique mesh shield that helps prevent the release of plaque and blood clots during and after stent placement, reducing the risk of complications such as strokes and heart attacks.
The CGuard EPS is built on the company's MicroNet technology, a specialized mesh material that offers superior embolic protection compared to traditional stenting procedures. The MicroNet technology acts as a barrier by capturing and containing debris that may break off during stent placement, preventing it from reaching vital organs such as the brain or heart.
The CGuard EPS has received regulatory approvals in various regions around the world, including the CE Mark in Europe and clearance from the US Food and Drug Administration (FDA). This regulatory success has allowed InspireMD to market and sell their product to healthcare professionals globally.
InspireMD is known for its dedication to research and development (R&D) and continually strives to improve and expand their product offerings. The company conducts numerous clinical trials and collaborations with leading medical institutions to gain valuable insights and validate the effectiveness of their technologies.
Furthermore, InspireMD has a strong focus on commercialization, forging strategic partnerships with distributors and healthcare companies to ensure widespread adoption of their products. They have established a global sales network to reach healthcare providers and patients in different countries.
Apart from the CGuard EPS, InspireMD also develops and markets other products for the treatment of various cardiovascular conditions. These include the MGuard Prime Embolic Protection System, which provides embolic protection during the treatment of heart attack patients.
Overall, InspireMD Inc is a leading medical device company that pioneers innovative solutions for the treatment of acute coronary syndromes. They are committed to improving patient outcomes by reducing the risk of complications associated with traditional stenting procedures. With their cutting-edge technology, extensive research, and strategic partnerships, InspireMD continues to make significant contributions to the field of interventional cardiology.
InspireMD Inc. is a medical device company known for its innovative solutions in the field of cardiovascular care, particularly in the area of stent technology. The company focuses on developing and commercializing products designed to address significant clinical needs in patients with coronary artery disease and other vascular conditions. Below is an extensive overview of the segments, products, and services offered by InspireMD Inc.
Segments
1. Cardiovascular Devices
- This is the core segment of InspireMDs offerings, centered around treatment options for patients with arterial disease. The products developed in this segment primarily focus on improving patient outcomes in coronary and peripheral artery interventions.
2. Interventional Cardiology
- This segment encompasses devices used during minimally invasive procedures to treat a variety of cardiovascular conditions. The company provides specialized devices that assist interventional cardiologists in their efforts to restore blood flow and improve the heart’s function.
3. Clinical Research and Trials
- InspireMD engages in clinical research to ensure that its products are safe and effective. The company often collaborates with healthcare institutions to conduct trials, gather evidence on the efficacy of its devices, and contribute to ongoing advancements in cardiovascular care.
Products
1. MGuard Coronary Stent System
- The flagship product of InspireMD, the MGuard Coronary Stent is a unique device that combines a traditional drug-eluting stent with a protective mesh overlay. This mesh is designed to capture any debris or thrombosis that could dislodge during the procedure, potentially preventing complications.
2. MGuard Prime Stent
- An evolution of the original MGuard, the MGuard Prime incorporates design enhancements aimed at improving deliverability and performance during interventional procedures. It maintains the protective mesh technology that characterizes the MGuard series and is specifically tailored for use in complex lesions.
3. MGuard Bioactive Stent
- This product features bioactive technology designed to reduce restenosis following percutaneous coronary interventions. The bioactive coating aims to promote healing while preventing scar tissue formation that can lead to complications.
4. CGuard Embolic Filter System
- Aimed at preventing embolic events during carotid artery interventions, the CGuard system utilizes a unique mesh structure to filter and capture any debris that may dislodge during the procedure. This product is particularly important in maintaining cerebral blood flow and protecting against stroke.
5. Periphery and Neurovascular Applications
- InspireMD has extended its innovative stent technology to peripheral and neurovascular applications, developing devices tailored for treating stenosis and occlusions in peripheral arteries, such as those in the legs and for applications in the neurovascular system.
Services
1. Technical Support and Training
- InspireMD provides extensive support services to healthcare professionals, including training on the proper use and deployment of its devices. This is crucial, as device proficiency can significantly impact patient outcomes during interventional procedures.
2. Clinical Collaboration
- The company actively collaborates with hospitals and academic institutions to facilitate clinical trials and research. By working with healthcare professionals, InspireMD can gather valuable feedback and data to improve its product offerings.
3. Regulatory Support
- InspireMD assists healthcare providers in understanding the regulatory landscape for new devices, helping them navigate the approval process for using these innovative products in clinical settings.
4. Education and Awareness Programs
- InspireMD conducts educational initiatives aimed at raising awareness about cardiovascular diseases and the importance of new treatment options. These programs target healthcare providers, patients, and the general public, aiming to improve knowledge and outcomes related to heart health.
Conclusion
InspireMD Inc. stands out in the medical device industry with its commitment to innovative stent technology and a comprehensive approach to cardiovascular care. By focusing on research and development, alongside extensive clinical support and training for healthcare professionals, InspireMD seeks to enhance patient outcomes and establish itself as a leader in the treatment of vascular diseases. The company continues to evolve its product line to address emerging needs in the cardiovascular space while upholding safety and effectiveness as primary objectives.
Segments
1. Cardiovascular Devices
- This is the core segment of InspireMDs offerings, centered around treatment options for patients with arterial disease. The products developed in this segment primarily focus on improving patient outcomes in coronary and peripheral artery interventions.
2. Interventional Cardiology
- This segment encompasses devices used during minimally invasive procedures to treat a variety of cardiovascular conditions. The company provides specialized devices that assist interventional cardiologists in their efforts to restore blood flow and improve the heart’s function.
3. Clinical Research and Trials
- InspireMD engages in clinical research to ensure that its products are safe and effective. The company often collaborates with healthcare institutions to conduct trials, gather evidence on the efficacy of its devices, and contribute to ongoing advancements in cardiovascular care.
Products
1. MGuard Coronary Stent System
- The flagship product of InspireMD, the MGuard Coronary Stent is a unique device that combines a traditional drug-eluting stent with a protective mesh overlay. This mesh is designed to capture any debris or thrombosis that could dislodge during the procedure, potentially preventing complications.
2. MGuard Prime Stent
- An evolution of the original MGuard, the MGuard Prime incorporates design enhancements aimed at improving deliverability and performance during interventional procedures. It maintains the protective mesh technology that characterizes the MGuard series and is specifically tailored for use in complex lesions.
3. MGuard Bioactive Stent
- This product features bioactive technology designed to reduce restenosis following percutaneous coronary interventions. The bioactive coating aims to promote healing while preventing scar tissue formation that can lead to complications.
4. CGuard Embolic Filter System
- Aimed at preventing embolic events during carotid artery interventions, the CGuard system utilizes a unique mesh structure to filter and capture any debris that may dislodge during the procedure. This product is particularly important in maintaining cerebral blood flow and protecting against stroke.
5. Periphery and Neurovascular Applications
- InspireMD has extended its innovative stent technology to peripheral and neurovascular applications, developing devices tailored for treating stenosis and occlusions in peripheral arteries, such as those in the legs and for applications in the neurovascular system.
Services
1. Technical Support and Training
- InspireMD provides extensive support services to healthcare professionals, including training on the proper use and deployment of its devices. This is crucial, as device proficiency can significantly impact patient outcomes during interventional procedures.
2. Clinical Collaboration
- The company actively collaborates with hospitals and academic institutions to facilitate clinical trials and research. By working with healthcare professionals, InspireMD can gather valuable feedback and data to improve its product offerings.
3. Regulatory Support
- InspireMD assists healthcare providers in understanding the regulatory landscape for new devices, helping them navigate the approval process for using these innovative products in clinical settings.
4. Education and Awareness Programs
- InspireMD conducts educational initiatives aimed at raising awareness about cardiovascular diseases and the importance of new treatment options. These programs target healthcare providers, patients, and the general public, aiming to improve knowledge and outcomes related to heart health.
Conclusion
InspireMD Inc. stands out in the medical device industry with its commitment to innovative stent technology and a comprehensive approach to cardiovascular care. By focusing on research and development, alongside extensive clinical support and training for healthcare professionals, InspireMD seeks to enhance patient outcomes and establish itself as a leader in the treatment of vascular diseases. The company continues to evolve its product line to address emerging needs in the cardiovascular space while upholding safety and effectiveness as primary objectives.